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Free radicalsIn this study, mice lacking the gp91phox gene were used to address the role of NADPH oxidase in
hyperhomocysteinemia-induced podocyte injury. It was found that a folate-free diet increased plasma
homocysteine levels, but failed to increase O2•− production in the glomeruli from gp91phox gene knockout
(gp91−/−) mice, compared with wild-type (gp91+/+) mice. Proteinuria and glomerular damage index (GDI)
were significantly lower, whereas the glomerular filtration rate (GFR) was higher in gp91−/− than in gp91+/+
mice when they were on the folate-free diet (urine albumin excretion, 21.23±1.88 vs 32.86±4.03 μg/24 h;
GDI, 1.17±0.18 vs 2.59±0.49; and GFR, 53.01±4.69 vs 40.98±1.44 μl/min). Hyperhomocysteinemia-
induced decrease in nephrin expression and increase in desmin expression in gp91+/+ mice were
not observed in gp91−/− mice. Morphologically, foot process effacement and podocyte loss due to
hyperhomocysteinemia were significantly attenuated in gp91−/− mice. In in vitro studies of podocytes,
homocysteine was found to increase gp91phox expression and O2•− generation, which was substantially
inhibited by gp91phox siRNA. Functionally, homocysteine-induced decrease in vascular endothelial growth
factor-A production was abolished by gp91phox siRNA or diphenyleneiodonium, a NADPH oxidase inhibitor.
These results suggest that the functional integrity of NADPH oxidase is essential for hyperhomocysteinemia-
induced podocyte injury and glomerulosclerosis.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Hyperhomocysteinemia (hHcys) has been known as a critical
pathogenic factor both in the progression of end-stage renal disease
(ESRD) and in the development of cardiovascular complications
related to ESRD [1–3]. It has been reported that sustained hHcys may
induce extracellular matrix accumulation and inhibit their degrada-
tion in the kidney, which ultimately leads to glomerulosclerosis [4].
Although many downstream signaling pathways are involved in
hHcys-induced glomerulosclerosis, reactive oxygen species (ROS) are
currently regarded as one of the most important mediators in the
initiation of hHcys-induced kidney damage. Among ROS, superoxide
(O2•−) is a main source for other oxygen-centered radicals, such as
H2O2 and •OH, which participate in lipid peroxidation and induce
cellular membrane damage. Emerging evidence has highlighted the
important role for the nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase-dependent system as a major source of O2•− in the
kidney [5]. Recently, we and others have shown that NADPH oxidase
activation and subsequent O2•− generation are important mechanisms
in the development of hHcys-induced glomerulosclerosis [6,7].
NADPH oxidase comprises the membrane-bound cytochrome b558
(formed by gp91phox and p22phox subunits) and the cytosolic proteins
p40phox, p47phox, p67phox, and Rac1/2. The catalytic subunits of thisenzyme are termed NOX proteins, which include NOX1, NOX2 (i.e.,
gp91phox), NOX3, NOX4, NOX5, DUOX1, and DUOX2 [8]. It has been
reported that almost all components of the NADPH oxidase complex,
including gp91phox, p22phox, p47phox, p67phox, and Rac1/2, are
expressed in the kidney and that these NADPH oxidase components
could be detected in renal fibroblasts, endothelial cells, vascular
smooth muscle cells, mesangial cells, and tubular cells [9]. Among
these, the catalytic subunit gp91phox was shown to be essential for
oxidative stress in the kidney. Previous studies using gp91phox
knockout mice have demonstrated that this enzyme plays important
roles in the maintenance of renal vascular tone [10], as well as in the
regulation of renal hemodynamics and excretory function under a
condition of nitric oxide deficiency [11]. Recently, several NADPH
oxidase subunits, gp91phox, p22phox, p67phox, and p47phox, have been
also demonstrated to be present in cultured podocytes [12]. Further
studies showed that NADPH oxidase activation and subsequent O2•−
production play a key role in high glucose-, angiotensin II-, and
adriamycin-induced podocyte injury [13–15]. However, it remains
unknown whether activation of NADPH oxidase is involved in hHcys-
induced podocyte injury and related pathological changes.
Podocytes are terminally differentiated epithelial cells,which cover
the outermost layer of glomerular filtration barrier and constitute the
last and themost important barrier in preventing protein leakage from
the plasma. Although podocyte injury has been considered as themost
important early event in initiating glomerulosclerosis and thereby
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involvement in hHcys-induced glomerular damage and sclerosis is
still poorly understood. We hypothesized that homocysteine (Hcys)
may directly cause podocyte injury through NADPH oxidase-
mediated O2•− production and that knockout or deletion of its
functional subunit, gp91phox, will protect podocytes from hHcys-
induced injury. To test this hypothesis, we determined the possible
injurious effect of hHcys on podocytes in mice lacking the gp91phox
gene and compared related pathological changes to their genetic
background strain C57BL/6 mice. We further used cultured murine
podocytes to examine the direct effects of gp91phox gene deletion on




C57BL/6J wild-type (WT; 6 weeks of age, male) and gp91phox
knockout (KO) mice (6 weeks of age, male; The Jackson Laboratory,
Bar Harbor, ME, USA) were used. All protocols were approved by the
Institutional Animal Care and Use Committee of the Virginia
Commonwealth University. Given the difficulty of the development
of hyperhomocysteinemia in mice with both kidneys because of
treatment that requires a long period of time, all gp91phox KOmice and
WT mice were subjected to a uninephrectomy, which helped
accelerate the progression of hHcys-induced glomerular injury, as
we reported previously [6]. This model was demonstrated to induce
glomerular damage unrelated to the uninephrectomy and arterial
blood pressure, but specific to hHcys. After a 1-week recovery period
from the uninephrectomy, KO andWTmice were fed a normal diet or
a folate-free (FF) diet (Dyets, Inc., Bethlehem, PA, USA) for 4 weeks to
induce hHcys. One day before these mice were sacrificed, 24-h urine
samples were collected using mouse metabolic cages. After blood
samples were collected, the mice were sacrificed and renal tissues
were harvested for biochemical and molecular analysis as well as
morphological examinations.
High-performance liquid chromatography (HPLC) analysis
Plasma total Hcys levels were measured by HPLC as we described
previously [19]. Briefly, blood samples were centrifuged at 1000g for
10 min at 4°C to isolate the plasma. One hundred microliters of
plasma, or standard solution mixed with 10 μl of internal standard,
thionglycolic acid (2.0 mmol/L) solution, was treated with 10 μl of
10% tri-n-butylphosphine solution in dimethylformamide at 4°C for
30 min. Then, 80 μl of ice-cold 10% trichloroacetic acid in 1 mmol/L
EDTA was added and centrifuged to remove proteins in the sample.
One hundred microliters of the supernatant was transferred into the
mixture of 20 μl of 1.55 mol/L sodium hydroxide, 250 μl of
0.125 mol/L borate buffer (pH 9.5), and 100 μl of 1.0 mg/ml ABD-F
solution. The resulting mixture was incubated at 60°C for 30 min to
accomplish derivatization of plasma thiols. HPLC was performed with
an HP 1100 series equipped with a binary pump, a vacuum degasser,
a thermostated column compartment, and an autosampler (Agilent
Technologies, Waldbronn, Germany). Separation was carried out at
ambient temperature on an analytical column, Supelco LC-18-DB
(1504.6-mm i.d., 5 m) with a Supelcosil LC-18 guard column (204.6-
mm i.d., 5 m). Fluorescence intensities were measured with an
excitation wavelength of 385 nm and emission wavelength of
515 nm by a Hewlett–Packard Model 1046A fluorescence spectro-
photometer. The peak area of the chromatographs was quantified
with a Hewlett–Packard 3392 integrator. The analytical column was
eluted with 0.1 mol/L potassium dihydrogen phosphate buffer
(pH 2.1) containing 6% acetonitrile (v/v) as the mobile phase with a
flow rate of 2.0 ml/min.Monitoring of arterial blood pressure in conscious mice
Mean arterial pressure (MAP) was measured 4 weeks after mice
were treated with the normal or FF diet as we described previously
[20]. In brief, mice were anesthetized by inhalation of isoflurane, and
then a catheter connected to a telemetry transmitter was implanted
into the carotid artery and the transmitter was placed subcutaneously.
The arterial blood pressure signal from the transmitter was received
by a remote receiver and then recorded by a computer program (Data
Sciences International, St. Paul, MN, USA). Arterial blood pressure was
continuously measured for 1 week after an equilibration period.
Electromagnetic spin resonance (ESR) analysis of O2
•− production
For detection of NADPH oxidase-dependent O2•− production,
proteins from the isolated glomeruli of mice or cultured podocytes
were extracted using sucrose buffer and resuspended with modified
Krebs–Hepes buffer containing deferoximine (100 μmol/L; Sigma, St.
Louis, MO, USA) and diethyldithiocarbamate (5 μmol/L; Sigma).
NADPH oxidase-dependent O2•− production was examined in 50 μg of
protein in the presence or absence of superoxide dismutase (200 U/ml;
Sigma). The mixture was loaded in glass capillaries and immediately
analyzed for O2•− production kinetically for 10 min in a Miniscope
MS200 ESR spectrometer (Magnettech Ltd., Berlin, Germany) as we
described for other studies [21,22]. The ESR settings were as follows:
biofield, 3350; field sweep, 60 G; microwave frequency, 9.78 GHz;
microwave power, 20mW;modulation amplitude, 3 G; 4096 points of
resolution; receiver gain, 20 for tissue and 50 for cells. The resultswere
expressed as the fold changes of control.
Measurement of creatinine clearance (Ccr)
Plasma and urinary creatinine concentrations (Pcr and Ucr) were
measured as described before [23]. In brief, 24-h urine samples were
collected using metabolic cages. Blood samples for serum creatinine
were collected at the time themicewere sacrificed. Serum and urinary
creatinine concentrationsweremeasuredbyaQuantiChromcreatinine
assay kit (BioAssay Systems, Hayward, CA, USA). Ccr was calculated
using the following formula: Ccr (μl/min)=(Ucr/Pcr)×urine volume
(μl/min).
Urinary total protein and albumin excretion measurement
The 24-h urine samples were collected using metabolic cages and
subjected to total protein and albumin excretion measurement,
respectively. Total protein content in the urine was detected by the
Bradford method using a UV spectrometer. Urine albumin was
detected using a commercially available mouse albumin ELISA kit
(Bethyl Laboratories, Montgomery, TX, USA).
Morphological examination
For observation of renal morphology using light microscopy, renal
tissues were fixed with 10% formalin solution, paraffin-embedded,
and stained with periodic acid–Schiff (PAS). Glomerular sclerosis was
assessed by a standard semiquantitative analysis and expressed as
glomerular damage index (GDI) [24]. Fifty glomeruli per slide were
counted and graded as 0, 1, 2, 3, or 4, according to 0, b25, 25–50,
51–75, or N75% sclerotic changes across a longitudinal kidney section,
respectively. The GDI for each mouse was calculated by the formula
((N1×1) + (N2×2) + (N3×3) + (N4×4))/n, where N1, N2, N3, and
N4 represent the numbers of glomeruli exhibiting grades 1, 2, 3, and 4,
respectively, and n is the total number of glomeruli graded.
For transmission electron microscopic (TEM) observation of
ultrastructural changes in podocytes, the kidneys were perfused
with afixative containing 3% glutaraldehyde and4%paraformaldehyde
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cortical strips were cut into 1-mm3 tissue blocks, which were further
fixed with 3% glutaraldehyde for 12 h. After dehydration with ethanol,
the sampleswere embedded inDurcupan resin for ultrathin sectioning
and TEM examinations by the VCU electron microscopy core facility.
Real-time reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from isolated mouse glomeruli or cultured podocytes
was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
according to the protocol as described by the manufacturer. RNA
samples were quantified by measurement of optic absorbance at 260
and 280 nm in a spectrophotometer. The concentrations of RNA were
calculated according to A260. Aliquots of total RNA (1 μg) from each
sample were reverse-transcribed into cDNA according to the instruc-
tions of the first-strand cDNA synthesis kit manufacturer (Bio-Rad,
Hercules, CA, USA). Equal amounts of the reverse-transcriptional
products were subjected to PCR amplification using SYBR green as the
fluorescence indicator on a Bio-Rad iCycler system (Bio-Rad). The
mRNA levels of target genes were normalized to the β-actin mRNA
levels. The primers used in this study were synthesized by Operon
(Huntsville, AL, USA) and the sequences were gp91phox, sense TGGCA
CATCGATCCCTCACTGAAA, antisense GGTCACTGCATCTAAGGCAACCT;
vascular endothelial growth factor-A (VEGF-A), sense CAATGAT-
GAAGCCCTGGAG, antisense TCTCCTATGTGCTGGCTTTG; and β-actin,
sense TCGCTGCGCTGGTCGTC, antisense GGCCTCGTCACCCACATAGGA.
Immunofluorescent staining and immunohistochemistry
Indirect immunofluorescent staining was performed using frozen
slides of mouse kidneys. After fixation with acetone, the slides were
incubated with rabbit anti-nephrin 1:100 (Abcam, Cambridge, MA,
USA), rabbit anti-podocin 1:200 (Sigma), or rabbit anti-desmin 1:100
(BD Biosciences, San Jose, CA, USA), overnight, at 4°C. Then, the slides
werewashedand incubatedwith corresponding FITC-labeled secondary
antibodies. Finally, the slides were washed, mounted, and subjected to
fluorescencemicroscopy examination. The imageswere capturedwith a
Spot CCD camera (Diagnostic Instruments, Sterling Heights, MI, USA).
All exposure settings were kept constant for each group of kidneys.
Because WT1 (Wilms' tumor suppressor gene) is exclusively
expressed by podocytes and not by other cell types in the glomeruli,
podocyte numbers were counted in mouse glomeruli using immuno-
histochemistry staining for WT1 as reported previously [25]. Briefly,
kidney sections from paraffin-embedded tissues were prepared at 4-
μm thickness and stained by an antibody to WT1 (1:50 dilution;
Abcam) using a routine immunohistochemistry procedure. After
staining, 50 consecutive glomerular cross sections per mouse were
randomly chosen and the positively stained podocytes were counted
by an observer who was blinded to the sample identity. Six mice were
analyzed for each group. The number of podocytes per glomerulus
was calculated from podocyte density multiplied by the glomerular
volume as described before [26].
Cell culture
A conditionally immortalized mouse podocyte cell line, kindly
provided by Dr. P.E. Klotman (Division of Nephrology, Department of
Medicine, Mount Sinai School of Medicine, New York, NY, USA), was
cultured on collagen I-coated flasks or plates in RPMI 1640 medium
supplemented with recombinant mouse interferon-γ at 33°C. After
differentiating at 37°C for 10–14 days without interferon-γ, the
podocytes were used for the proposed experiments. In this study, the
preparation of L-Hcys (a pathogenic form of Hcys) and the
concentration and incubation time of L-Hcys treatment were chosen
based on our previous studies in mesangial cells [27] and our
preliminary experiments on podocytes.Gp91phox siRNA transfection
Gp91phox siRNA, purchased from Qiagen (Valencia, CA, USA), was
confirmed to be effective in silencing the gp91phox gene in various cells
by the company. The scrambled RNA (sRNA; Qiagen) was confirmed
as nonsilencing double-stranded RNA and used as the control in this
study. Podocytes were serum starved for 12 h and then transfected
with gp91phox siRNA or sRNA using the siLentFect lipid reagent (Bio-
Rad). After 18 h of incubation at 37°C, themediumwas changed and L-
Hcys (80 μmol/L) added into the medium for the indicated times.
ELISA for VEGF-A secretion in podocytes
After being transfected with gp91phox siRNA or sRNA, or pretreated
with diphenyleneiodonium (DPI; a NADPH oxidase inhibitor),
podocytes were incubated with L-Hcys (80 μmol/L) for 24 h. A
relatively specific podocyte injury compound, puromycin aminonu-
cleoside (PAN; 100 μg/ml), was used to treat cells for 24 h to serve as a
positive control. The supernatant was collected for ELISA of VEGF-A
using a commercially available kit (R&D Systems, Minneapolis, MN,
USA).
Statistical analysis
All of the values are expressed as means±SEM. Significant
differences among multiple groups were examined using ANOVA
followed by a Student–Newman–Keuls test. The χ2 test was used to
access the significance of ratio and percentage data. Pb0.05 was
considered statistically significant.
Results
Reduction of hHcys-induced O2
•− production in gp91phox KO mice
As shown by HPLC analysis, plasma Hcys levels were similar in WT
and gp91phox KO mice on the normal diet. FF diet treatment
significantly increased plasma Hcys levels in both WT and gp91phox
KO mice (Fig. 1A). ESR analysis showed that glomerular O2•−
production was lower in KO mice than in WT mice on the normal
diet. On the FF diet, glomerular O2•− production increased by 2.4-fold
in WT mice. However, FF diet-induced O2•− production was much less
in KO mice compared with WT mice (Figs. 1B and 1C).
Alleviation of glomerular injury in gp91phox KO mice on the FF diet
In parallel to the elevation in plasma Hcys levels, the 24-h urinary
total protein and albumin excretion was significantly increased in WT
mice on the FF diet. In gp91phox KO mice, however, a similar level of
plasma Hcys caused much less urinary total protein and albumin
excretion (Figs. 2A and 2B). By PAS staining, we observed a typical
pathological change in glomerular sclerotic damage inWTmice on the
FF diet (Fig. 3A). The average GDI was substantially higher inWTmice
on the FF diet, but much less in gp91phox KO mice on the same diet
(Pb0.05, Fig. 3B). To evaluate the glomerular filtration rate (GFR) of
these mice, Ccr was measured. It was found that FF diet treatment
induced a decline in Ccr in WT mice, whereas the Ccr was mostly
preserved in gp91phox KO mice on the same diet (Fig. 4A). To explore
whether these renal functional and pathological changes were
associated with elevation of arterial blood pressure, MAP was
measured in conscious mice using telemetry. FF diet treatment had
no effect on MAP in either WT or KO mice (Fig. 4B).
Expression of nephrin, podocin, and desmin in gp91phox KO and WT mice
Next we determined whether the protective effect of gp91phox
gene knockout is associated with the protection of podocytes from
Fig. 1. Effects of normal and FF diets on plasma Hcys levels and glomerular O2•−
production in gp91phox KO and WT mice. (A) Plasma Hcys levels measured by HPLC in
four groups of mice (n=6). (B) Representative ESR spectra traces for O2•− production in
gp91phox KO and WT mice (n=5). (C) Summarized data show the fold changes in O2•−
production, which are normalized to WT mice on the normal diet (n=5). ⁎Pb0.05 vs
WT mice on the normal diet; #Pb0.05 vs WT mice on the FF diet; &Pb0.05 vs KO mice
on the normal diet.
Fig. 2. Proteinuria was attenuated in gp91phox KO mice on the FF diet. (A) Urinary total
protein levels in the four groups of mice (n=6). (B) Urinary albumin excretion in the
four groups of mice (n=6). ⁎Pb0.05 vs WT mice on the normal diet; #Pb0.05 vs WT
mice on the FF diet; &Pb0.05 vs KO mice on the normal diet.
Fig. 3. Glomerular damage was alleviated in gp91phox KO mice on the FF diet. (A) PAS
staining shows glomerular morphological changes (original magnification, ×400). (B)
Summarized data of GDI by semiquantitation of scores in the four groups of mice (for
each group, n=6). For each kidney section, 50 glomeruli were randomly chosen for the
calculation of GDI. ⁎Pb0.05 vsWTmice on the normal diet; #Pb0.05 vs WTmice on the
FF diet.
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mRNA levels of two important slit diaphragm molecules, nephrin
and podocin, were significantly decreased by the FF diet in WT mice,
which decrease was much less in KO mice on the same diet. However,
the expression of desmin, a podocyte injury marker, was significantly
increased in WT mice on the FF diet compared with gp91phox KO mice
(Pb0.05, Fig. 5A). As shown by indirect immunofluorescent staining in
Fig. 5B, nephrin and podocin staining was seen as a fine linear-like
pattern along the glomerular capillary loop in mice on a normal diet.
The expression of both nephrin and podocin showed a dramatic
decrease in WT mice on the FF diet, which was less obvious in the
gp91phox KO mice on the same diet. In contrast, the expression of
desmin was less increased in gp91phox KO mice on the FF diet
compared with WT mice.
Attenuation of hHcys-induced foot process effacement and podocyte loss
in gp91phox KO mice
To observe ultrastructural changes in podocytes, TEM was
conducted. Compared with the distinct brush-like structures of
podocyte foot processes seen in mice on the normal diet, evident
foot process effacement was observed in WT mice 4 weeks after FF
diet treatment. In contrast, podocytes of gp91phox KO mice on the FFdiet had relatively normal ultrastructures (Fig. 6A). To investigate
whether gp91phox gene knockout helps to maintain podocyte
numbers, we counted the number of podocytes per glomerular cross
Fig. 4. Ccr and arterial blood pressure in gp91phox KO and WT mice. (A) Creatinine
clearance in WT and KO mice on a normal or FF diet (n=7). (B) MAP in WT and KO
mice with or without FF diet (n=5). ⁎Pb0.05 vs WT mice on the normal diet; #Pb0.05
vs WT mice on the FF diet.
Fig. 5. Expression of nephrin, podocin, and desmin in gp91phox KO and WT mice. (A)
Real-time RT-PCR analysis of the expression of nephrin, podocin, and desmin in the
glomeruli of gp91phox KO and WT mice (n=6). (B) Immunofluorescent staining of
nephrin, podocin, and desmin in the glomeruli of the four groups of mice (n=4).
⁎Pb0.05 vs WT mice on the normal diet; #Pb0.05 vs WT mice on the FF diet; &Pb0.05
vs KO mice on the normal diet.
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with an antibody against the podocyte-specific marker WT1. There
were similar numbers of WT1-stained podocytes in WT and KO mice
fed a normal diet. FF diet treatment induced a significant decrease in
podocyte numbers in WT mice, but not in KO mice (Figs. 6B and 6C).
Blockade of Hcys-induced O2
•− production by gp91phox gene silencing in
cultured podocytes
Although we have demonstrated in whole-animal experiments
that the glomeruli of gp91phox KO mice were protected from hHcys-
induced renal injury, it has yet to be determined whether such
protective action is due to the direct protection of podocytes. To
address this issue and to explore potential underlying mechanisms,
we used in vitro cultured podocytes to examine the role of gp91phox-
containing NADPH oxidase in Hcys-induced podocyte injury. Real-
time RT-PCR showed that L-Hcys stimulated the expression of
gp91phox at both the mRNA and the protein level (Pb0.05, Fig. 7A).
This increased gp91phox expression was accompanied by an elevated
NADPH oxidase-dependent O2•− production (Fig. 7B).When podocytes
were transfected with gp91phox siRNA, Hcys-induced O2•− production
was significantly inhibited, whichwas comparable to the inhibition by
DPI, a NADPH oxidase inhibitor (Pb0.05, Fig. 7C).
Blockade of Hcys-induced decrease in VEGF-A secretion in podocytes by
gp91phox siRNA gene silencing
As a functional parameter of podocytes, VEGF-A production was
detected in podocytes under various conditions. Fig. 8A shows that the
mRNA expression of VEGF-A was decreased by L-Hcys in a concentra-
tion-dependent manner. As shown in Figs. 8B and 8C, VEGF-A
production and secretion were dramatically reduced by the treatment
with L-Hcys (Pb0.05), which was similar to the designated positive
control, PAN. When gp91phox siRNA was transfected to inhibit O2•−
production via NADPH oxidase, Hcys-induced decrease in VEGF-Asecretion was significantly restored (Pb0.05). Similarly, inhibition of
NADPH oxidase activity using DPI also recovered VEGF secretion in
podocytes.
Discussion
The goals of this study were to determine whether podocytes are a
direct target of hHcys and to investigate the role of NADPH oxidase-
dependent O2•− production in hHcys-induced podocyte injury. Using
an FF diet-induced hHcys animal model in gp91phox gene-deficient
mice and in vitro cultured podocytes, we clearly demonstrated that
hHcys directly induces podocyte injury and depletion through
gp91phox-containing NADPH oxidase activation and O2•− production.
There is considerable evidence supporting the critical role of ROS,
particularly O2•−, in the pathogenesis of kidney diseases, such as
diabetic nephropathy [28] and hypertension-related nephropathy
[29]. Among various enzymes involved in the generation of ROS,
NADPH oxidase is regarded as the main source of O2•− production.
Fig. 6. Attenuation of foot process effacement and podocyte loss in the glomeruli of
gp91phox KO mice. (A) gp91phox gene deletion improved podocyte ultrastructure in FF
diet-treated mice. Arrow denotes the area of foot process effacement in WT mouse on
the FF diet. Images are representative of six TEM images per kidney from three mice per
group. Original magnification, ×8000. (B) Typical images of WT1-stained glomeruli
from the four groups of mice (original magnification, ×400). (C) Summarized data
showing podocyte numbers per glomerulus in each group (n=6). ⁎Pb0.05 vs WT mice
on the normal diet; #Pb0.05 vs WT mice on the FF diet.
Fig. 7. L-Hcys increases gp91phox expression and NADPH oxidase-dependent O2•−
production in cultured podocytes. (A) L-Hcys stimulation for 12 h caused elevated
gp91phoxmRNA expression in podocytes as determined by real-time RT-PCR (n=4). (B)
ESR analysis shows that Hcys induces O2•− production in a concentration-dependent
manner in podocytes (n=5). (C) ESR analysis shows that gp91phox siRNA transfection
or NADPH oxidase inhibition by DPI reduces O2•− production in podocytes. Ctrl, control;
Vehl, vehicle; Scra, scrambled RNA; siRNA, gp91phox siRNA (n=6). ⁎Pb0.05 vs control,
#Pb0.05 vs Hcys.
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oxidase. Although there are some reports indicating that NOX1 and
NOX4 are also expressed in the kidney [30,31], data from our
laboratory and other groups have strongly suggested that the
gp91phox-containing NADPH oxidase system is more critical in
mediating O2•− production in the kidney [4,10,11,32]. Therefore, we
used gp91phox-deficient mice to explore the role of NADPH oxidase-
mediated O2•− production in hHcys-induced podocyte injury. It was
found that the FF diet treatment increased plasma Hcys levels in both
WT and KO mice, which indicates a successful establishment of the
hHcys model and also suggests that gp91phox itself is not involved in
the metabolism of Hcys. Gp91phox KO mice on the FF diet exhibited a
lower level of renal O2•− production compared with WT mice,
implying that gp91phox gene deficiency prevents hHcys-induced
local O2•− production in the kidney. In previous studies, gp91phox KO
mice have also been reported to have lowered O2•− production in
many organs, such as the heart, lungs, and brain, which protects these
mice from various pathophysiological conditions such as cardiac
hypertrophy [8], hypoxic pulmonary hypertension [33], and surgicallyinduced brain injury [34]. In accordancewith loweredO2•− production
in gp91phox KO mice on the FF diet, urine albumin excretion in these
micewas significantly decreased comparedwithWTmice on the same
diet, suggesting that ROS-associated renal injury during hHcys is
alleviated in these KO mice. Pathological studies using PAS staining
showed that there was a significant improvement of hHcys-induced
glomerulosclerosis in these KO mice compared with WT mice.
Consistent with these pathological changes, GFR was also preserved
in these KOmice on the FF diet. In addition, a 4-week FF diet treatment
had no influence on arterial blood pressure of WT and gp91phox KO
mice, indicating that the preservation of podocyte function and
structure in these KO mice is not associated with any change in blood
pressure. All these results support the view that gp91phox-containing
NADPH oxidase mediates O2•− production in the glomeruli and
thereby plays a critical role in hHcys-induced renal injury.
One of the most important findings of this study is that gp91phox
gene deficiency may protect podocytes from hHcys-induced injury.
Fig. 8. Effects of gp91phox gene silencing on L-Hcys-induced decrease in VEGF-A
production and secretion in podocytes. (A) Real-time RT-PCR analysis shows that Hcys
stimulation for 12 h decreases VEGF-A mRNA levels in a concentration-dependent
manner (n=4). (B) Real-time RT-PCR analysis shows the expression of VEGF-A mRNA
challenged by Hcys (80 μmol/L) for 12 h with various pretreatments. PANwas used as a
positive control (n=4). (C) VEGF-A secretion in the culture medium detected by ELISA
after pretreatment with various inhibitors and Hcys for 24 h. Ctrl, control; Vehl, vehicle;
Scra, scrambled RNA; siRNA, gp91phox siRNA (n=5). ⁎Pb0.05 vs control. #Pb0.05 vs
Hcys.
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protein loss in the normal glomerulus [35]. Damage to podocytes and
their slit diaphragm is intimately associated with proteinuria and
glomerulosclerosis in many kidney diseases, such as focal segmental
glomerulosclerosis, diabetic nephropathy, and hypertension-associated
nephropathy [36,37]. In recent studies, we have reported that foot
process effacement was presented in a methionine-induced animal
model of hHcys [23], but the mechanism has not yet been explored.
Here, we demonstrated for the first time that hHcys could induce
podocyte injury through NADPH oxidase-mediated O2•− production,
which was supported by analysis of the levels of some slit diaphragm
molecules such as nephrin and podocin and by measuring the
podocyte damage marker desmin. As is well known, nephrin and
podocin are two important components of the slit diaphragm
complex, which play an essential role in maintaining the normal
structure of the glomerular filtration barrier. Mutation or down-regulation of these proteins is associated with a defective filtration
barrier causing proteinuria [38]. In addition, nephrin affords
important signaling cascades through its interaction with podocin
and CD2-associated protein (CD2AP) for maintaining the normal
growth of podocytes and preventing their apoptosis [38]. So, the
decreased expression of nephrin is not only an indicator of slit
diaphragm damage, but also a sign of a disturbed intracellular
signaling pathway that is essential for podocyte survival. The results
from this study show that hHcys induced a dramatic decrease in
nephrin and podocin expression in WT mice, but not in gp91phox KO
mice. It seems that hHcys may disrupt the normal structure of the
slit diaphragm complex and the related intracellular signaling events
through NADPH oxidase-mediated O2•− production. This Hcys-
induced podocyte injury and its attenuation in gp91phox KO mice
were also demonstrated by the increase in desmin expression.
Desmin is an intermediate filament protein, which has long been
suggested as a specific and sensitive podocyte injury indicator [7], and
its expression is often up-regulated in various glomerular diseases in
which podocyte damage is involved [18,39]. In this study, we showed
that hHcys induced by the FF diet significantly increased desmin
expression in the glomeruli ofWTmice, butmuch less in gp91phox gene
KO mice, further suggesting that podocyte injury is significantly
attenuated because of reduced O2•− generation in the kidney.
Among various morphologic characteristics, foot process efface-
ment and consequent podocyte depletion are strong predictors for the
progression of glomerulosclerosis. It has been proposed that the loss
of b20% of podocytes triggers mesangial expansion, loss of 20–40%
produces small patches of podocyte depletion and synechia forma-
tion, and N40% podocyte depletion produces the full picture of focal
segmental glomerulosclerosis with segmental and eventually global
sclerosis [40]. Although these observations identify podocyte deple-
tion as one of the earliest cellular features of many types of kidney
diseases, the mechanisms underlying the loss of podocytes remain
poorly understood. Recently, it has been demonstrated ROS activation
is a key mechanism leading to podocyte loss in animal models of
diabetic nephropathy [13] and PAN-induced nephropathy [41]. In this
study, the TEM data showed that FF diet treatment caused podocyte
foot process effacement in WT mice, and such damage was
dramatically attenuated in gp91phox KO mice on the same diet. The
fact that gp91phox gene deletion provided protection from podocyte
foot process effacement indicates that this podocyte injury is a direct
action of hHcys on podocytes and it is through NADPH oxidase-
mediated ROS toxicity. Using WT1 staining to calculate podocyte
numbers and evaluate podocyte loss in the glomeruli, we found that
hHcys significantly decreased podocyte numbers in the glomeruli of
WT mice, indicating a podocyte loss under such pathological
conditions. Interestingly, gp91phox gene deletion prevented such
podocyte loss induced by hHcys. These results suggest that the
activation of NADPH oxidase and subsequent O2•− production is an
important mechanism in mediating Hcys-induced podocyte injury
and death. In harmony with our results, Liu et al. recently provided
evidence showing that up-regulation of NADPH oxidase activity plays
a pivotal role in mediating proximal tubular cell apoptosis in
transgenic mice overexpressing angiotensinogen [42]. It should be
noted that some previous studies reported the effects of hHcys in
inducing renal cell proliferation through the activation of NADPH
oxidase in other cell types such as mesangial cells [27]. It seems that
the action of NADPH oxidase in causing cell proliferation or deathmay
be cell-type specific. Although the function of NADPH oxidase-derived
ROS in mediating renal cell proliferation and death seems to be
paradoxical, these actions may eventually converge at the functional
level, in that both processes may be detrimental (for example,
proliferation of mesangial cells and depletion of podocytes) to normal
kidney functions [43].
To address whether this protective effect of gp91phox gene deletion
is directly associated with counteracting Hcys-induced injury to
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effects of gp91phox gene silencing on Hcys-induced functional changes.
It was found that Hcys induced an increase in the expression of
gp91phox and a dramatic enhancement of O2•− production in a
concentration-dependent manner, which was blocked when podo-
cytes were transfected with gp91phox siRNA. These results provide
evidence that Hcys is able to directly act on podocytes, initiating local
oxidative stress and resulting in podocyte injury via activation of
NADPH oxidase. In accordance with our findings, Eid et al.
demonstrated that NADPH oxidase-dependent O2•− generation also
mediates high-glucose-induced podocyte injury using the same cell
line as we used [13]. There is also another study indicating that
NADPH oxidase-mediated O2•− generation serves as the main
mediator of PAN-induced podocyte damage [44]. It seems that
NADPH oxidase-mediated O2•− production is an important detrimen-
tal factor in podocyte injury, which may initiate and promote
glomerulosclerosis.
To further investigate the functional abnormality of Hcys-
induced podocyte injury via NADPH oxidase activation, we
examined the production of VEGF-A in cultured podocytes. In the
kidney, VEGF-A is mainly derived from podocytes and regulates the
cytoskeletal organization and migration of glomerular endothelial
cells, facilitating the formation of a new vascular lumen [45]. A
recent report has demonstrated that podocytes have a functional
autocrine VEGF-A system, which is regulated by differentiation and
ligand availability [46]. The function of VEGF-A in podocytes
includes promoting cell survival through VEGFR2, inducing podocin
up-regulation, and increasing nephrin/CD2AP interaction [46].
VEGF-A may also serve as a crucial growth factor in maintaining
the normal function of podocytes by preventing their apoptosis
through the interaction with nephrin and activation of the AKT
signaling pathway [47]. Podocyte-derived VEGF-A is decreased in
sclerotic glomeruli [48], whereas treatment with exogenous VEGF-A
decreases renal sclerotic injuries and restores glomerular capillaries
[49]. In this study, we found that Hcys treatment significantly
decreased the production of VEGF-A in podocytes, which was
restored by silencing of the gp91phox gene or by inhibition of
NADPH oxidase activity. It seems that elevated O2•− production
induced by Hcys damages the normal function of podocytes to
secrete this important growth and permeability factor in the
glomeruli. Given the important role of VEGF in maintaining the
normal function of podocytes and preventing their apoptosis, it is
plausible that decreased nephrin expression, reduced VEGF excre-
tion, and subsequent disturbed VEGF–nephrin interaction induced
by hHcys may contribute importantly to Hcys-induced podocyte
depletion.
In summary, this is the first report showing that Hcys may directly
cause podocyte injury and depletion, which are important events
leading to glomerulosclerosis associated with hHcys. Using a gp91phox
gene KO mouse model, we found that all hHcys-induced structural
and functional changes reflecting podocyte injury were alleviated,
such as proteinuria, reduced expression of podocin and nephrin,
increased desmin level, foot process effacement, and podocyte loss. In
culturedmurine podocytes, we further demonstrated that silencing of
the gp91phox gene inhibited O2•− production induced by Hcys and
recovered Hcys-induced decrease in secretion of VEGF-A. Collectively,
these results demonstrate that a direct injurious effect of hHcys on
podocytes is mainly mediated by a mechanism that involves
generation of O2•− by the gp91phox-containing NADPH oxidase,
which may represent a specific early mechanism mediating hHcys-
induced glomerulosclerosis.
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